4-Aminoethylamino-emodin – a novel potent inhibitor of GSK-3β– acts as an insulin-sensitizer avoiding downstream effects of activated β-catenin

por Gebhardt, Rolf, Lerche, Katja S, Götschel, Frank, Günther, Robert, Kolander, Jens, Teich, Lars, Zellmer, Sebastian, Hofmann, Hans-Jörg, Eger, Kurt, Hecht, Andreas, Gaunitz, Frank
Publicado 2010